Terms: = Thyroid cancer AND PSA AND Treatment
21 results:
1. First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC).
Autio KA; Higano CS; Nordquist L; Appleman LJ; Zhang T; Zhu XH; Babiker H; Vogelzang NJ; Prasad SM; Schweizer MT; Madan RA; Billotte S; Cavazos N; Bogg O; Li R; Chan K; Cho H; Kaneda M; Wang IM; Zheng J; Tang SY; Hollingsworth R; Kern KA; Petrylak DP
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36948505
[TBL] [Abstract] [Full Text] [Related]
2. Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying psa Nadir ≤ 0.05 ng/ml as marker for treatment response.
Kafka M; Burtscher T; Fritz J; Schmitz M; Bektic J; Ladurner M; Horninger W; Heidegger I
World J Urol; 2023 Aug; 41(8):2043-2050. PubMed ID: 36287244
[TBL] [Abstract] [Full Text] [Related]
3. Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients.
Yadav MP; Ballal S; Sahoo RK; Tripathi M; Damle NA; Shamim SA; Kumar R; Seth A; Bal C
PLoS One; 2021; 16(5):e0251375. PubMed ID: 33970962
[TBL] [Abstract] [Full Text] [Related]
4. Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.
Klotz L
World J Urol; 2022 Jan; 40(1):1-8. PubMed ID: 33492425
[TBL] [Abstract] [Full Text] [Related]
5. Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.
Williams SG; Aw Yeang HX; Mitchell C; Caramia F; Byrne DJ; Fox SB; Haupt S; Schittenhelm RB; Neeson PJ; Haupt Y; Keam SP
BMC Urol; 2020 Oct; 20(1):171. PubMed ID: 33115461
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of serum psa in breast cancer patients.
Hanamura T; Ohno K; Hokibara S; Murasawa H; Nakamura T; Watanabe H; Kaizuka M; Sawano S; Koyama H; Ito KI
BMC Cancer; 2019 Oct; 19(1):1021. PubMed ID: 31664946
[TBL] [Abstract] [Full Text] [Related]
7. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.
Matthew EM; Zhou L; Yang Z; Dicker DT; Holder SL; Lim B; Harouaka R; Zheng SY; Drabick JJ; Lamparella NE; Truica CI; El-Deiry WS
Oncotarget; 2016 Jan; 7(4):3662-76. PubMed ID: 26695546
[TBL] [Abstract] [Full Text] [Related]
8. Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma.
Fujii R; Hanamura T; Suzuki T; Gohno T; Shibahara Y; Niwa T; Yamaguchi Y; Ohnuki K; Kakugawa Y; Hirakawa H; Ishida T; Sasano H; Ohuchi N; Hayashi S
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():513-22. PubMed ID: 25178713
[TBL] [Abstract] [Full Text] [Related]
9. Effect of high-dose intravenous vitamin C on inflammation in cancer patients.
Mikirova N; Casciari J; Rogers A; Taylor P
J Transl Med; 2012 Sep; 10():189. PubMed ID: 22963460
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial.
Lazarevic B; Boezelijn G; Diep LM; Kvernrod K; Ogren O; Ramberg H; Moen A; Wessel N; Berg RE; Egge-Jacobsen W; Hammarstrom C; Svindland A; Kucuk O; Saatcioglu F; Taskèn KA; Karlsen SJ
Nutr Cancer; 2011; 63(6):889-98. PubMed ID: 21714686
[TBL] [Abstract] [Full Text] [Related]
11. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
Trtková K; Pašková L; Matiješčuková N; Kolář Z
Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
[TBL] [Abstract] [Full Text] [Related]
12. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
13. Osteoporosis management in prostate cancer patients treated with androgen deprivation therapy.
Yee EF; White RE; Murata GH; Handanos C; Hoffman RM
J Gen Intern Med; 2007 Sep; 22(9):1305-10. PubMed ID: 17634780
[TBL] [Abstract] [Full Text] [Related]
14. A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors.
Alexandre J; Kahatt C; Bertheault-Cvitkovic F; Faivre S; Shibata S; Hilgers W; Goldwasser F; Lokiec F; Raymond E; Weems G; Shah A; MacDonald JR; Cvitkovic E
Invest New Drugs; 2007 Oct; 25(5):453-62. PubMed ID: 17628744
[TBL] [Abstract] [Full Text] [Related]
15. Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer.
Casu M; Cappi C; Patrone V; Repetto E; Giusti M; Minuto F; Murialdo G
Eur J Endocrinol; 2005 Jun; 152(6):819-24. PubMed ID: 15941920
[TBL] [Abstract] [Full Text] [Related]
16. Viral mediated gene therapy for the management of metastatic thyroid carcinoma.
DeGroot LJ; Zhang R
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):235-44. PubMed ID: 15379725
[TBL] [Abstract] [Full Text] [Related]
17. [A case report of distant lymph nodes metastases from prostate cancer imaged with 201Tl and 99mTc-MIBI].
Ikekubo K; Hino M; Ito H; Ohtsuka H; Saiki Y
Kaku Igaku; 2003 Nov; 40(4):439-43. PubMed ID: 14733108
[TBL] [Abstract] [Full Text] [Related]
18. [Prostate cancer with high serum level of CEA and CA19-9: a case report].
Momma T; Kimura S; Saito S; Onoda N
Hinyokika Kiyo; 1998 Mar; 44(3):187-91. PubMed ID: 9589883
[TBL] [Abstract] [Full Text] [Related]
19. [Alcohol sclerotherapy for benign solitary thyroid nodules].
Zieleźnik W; Sieroń A; Peszel-Barlik M; Zieleźnik M; Simon-Sieroń M
Wiad Lek; 1997; 50(7-9):211-6. PubMed ID: 9507690
[TBL] [Abstract] [Full Text] [Related]
20. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.
Esquenet M; Swinnen JV; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1995 Mar; 109(1):105-11. PubMed ID: 7540569
[TBL] [Abstract] [Full Text] [Related]
[Next]
